[ij] [ij] [ij] 
Email id

Year : 2021, Volume : 14, Issue : 2
First page : ( 1190) Last page : ( 1192)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2021.00212.2

Ulcerative colitis: A comprehensive review

Singh Niraj Kumar*

Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, 281406, India.

*Corresponding Author E-mail: niraj.singh0@gmail.com, niraj.singh@gla.ac.in

Online published on 30 April, 2021.


Ulcerative colitis (UC) is a common chronic inflammatory disorder that mainly affect large intestine. It started with mucosal inflammation and extends proximally in continuous way. The clear etiology of UC is not yet clear. The characteristic manifestations of UC include bloody diarrhea, fecal urgency, hematochezia and abdominal pain. The present study includes epidemiology, pathophysiology, diagnosis and available novel treatment options for UC. It is most important to rule out infectious and noninfectious etiology. Most cases of UC are treated with available pharmacological agents firstly for remission then maintenance of remission. First choice of drug for UC is 5-aminosalicylic acid with or without addition of corticosteroid depending upon response of mono-therapy. Patients nonresponsive to drug therapy should be hospitalized with critical care attention.



Ulcerative colitis, Chronic inflammatory disorder, Mucosal inflammation, Bloody stool, And Colonic mucin.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
772,840,385 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.